Subscribe to the Daily News Brief. Nearly half of all U.S. imports—more than $1.3 trillion—come from Canada, China, and Mexico. However, analysis by Bloomberg Economics shows that the new ...

That came after U.S. Treasury Secretary Scott Bessent reiterated the existing long-term debt sale plan and said the Trump administration is minded to inject downward pressure on the 10-year Treasury ...

Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...

AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...

AstraZeneca said it forecasts sales and earnings growth this year after fourth-quarter results beat expectations, as strength in its oncology business offset weak China sales, but warned of a ...

In November the company reported a third investigation in China involving two current and two former senior executives, relating to the import of AstraZeneca cancer drugs from Hong Kong.

UK drugmaker AstraZeneca overcame a drop in sales in China and the arrest of its top executive in the country to deliver an 18 per cent increase in revenues in the final quarter of 2024.

AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities investigate the company’s former China head. AZ has received a notice ...

Drugmaker AstraZeneca has warned it could face a fine in China over possible unpaid import taxes, as it revealed strong sales of cancer drugs helped drive revenues higher. AstraZeneca said ...

STORY: AstraZeneca shares rose more than 5% on Thursday (Feb 6). Investors were reassured after the drugmaker said a potential fine in China would have only a minor business impact. The company ...

AstraZeneca has warned it could face a fine in China over possible unpaid import taxes, as it revealed strong sales of cancer drugs helped lift revenues higher. The FTSE 100-listed drugmaker said ...